<?xml version="1.0" encoding="UTF-8"?>
<p>Phe(3-Am)-derived inhibitors, which may offer promising preventive or therapeutical strategy for treatment of COVID-19 via suppression of various host cell proteases essential for viral entry and replication, was applied and characterised in this study using human intestinal epithelial cells.</p>
